Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability

Abstract

The cause of the molecular defect of Fanconi anemia (FA) remains unknown. Cells from patients with FA exert an elevated spontaneous chromosomal instability which is further triggered by mitomycin C. The induced lability is reduced by overexpression of thioredoxin which is not the case for spontaneous instability. However, both are eliminated by overexpression of thioredoxin cDNA with an added nuclear localization signal. This implies that thioredoxin is lacking in the nuclei of FA cells. The total thioredoxin content in all FA cells tested is reduced. The resultant lack of nuclear thioredoxin can be the explanation for the major symptomatology in FA. Since thioredoxin is known to be the reactive cofactor of ribonucleotid reductase its shortcoming reduces the supply of deoxyribonucleotides thus hindering the DNA and replication repair with resultant chromosomal breaks. Furthermore, depression of tyrosine hydroxylase, the key enzyme of melanine synthesis, could be the basis for the pathognomotic ‘café au lait’ spots of FA. The observation of thioredoxin reduction in FA cells permits insight into the molecular phathophysiology of FA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 4
Figure 1
Figure 2
Figure 3
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Alter BP . 1993 Br. J. Haematol. 85: 9–14

  • Cumming RC, Lightfoot J, Beard K, Youssoufian H, O'Brien PJ, Buchwald M . 2001 Nat. Med. 7: 814–820

  • Dallapiccola B, Porfirio B, Mokini V, Alimena G, Isacchi G, Gandini E . 1985 Hum. Genet. 69: 62–65

  • Fanconi G . 1927 Jahrb Kinderheilkd. 117: 257–280

  • Fujii S, Nanbu Y, Konishi I, Mori T, Masutani H, Yodoi J . 1991 Virchows. Arch. Pathol. Anat. Histopathol. 419: 317–326

  • Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD . 2001 Mol. Cell 7: 249–262

  • Gille JJP, Wortelboer HM, Joenje H . 1987 Hum. Genet. 77: 28–31

  • Hirota K, Murata U, Sachi Y, Nakamura H, Takeuchi J, Mori K, Yodoi J . 1999 J. Biol. Chem. 274: 27891–27897

  • Holmgren A . 1985 Annu. Rev. Biochem. 54: 237–271

  • Izawa S, Maeda K, Sugiyama K, Mano J, Inoue Y, Kimura A . 1999 J. Biol. Chem. 274: 28459–28465

  • Joenje H, Arwert F, Eriksson AW, de Koning H, Oostra AB . 1981 Nature 290: 140–143

  • Korkina LG, Samochatova EV, Maschan AA, Suslova TB, Cheremisina ZP, Afanasev IB . 1992 J. Leukocyte Biol. 52: 357–362

  • Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, Taketo MM . 1996 Dev. Biol. 178: 179–185

  • Oliviera L, Bouton C, Drapier JC . 1999 J. Biol. Chem. 274: 516–521

  • Ramirez MH, Ruppitsch W, Hirsch-Kauffmann M, Schweiger M . 1999 Biochem. Biophys. Res. Commun. 264: 518–524

  • Rubartelli A, Bajetto A, Allavena G, Wollman E, Sitia R . 1992 J. Biol. Chem. 267: 24161–24164

  • Rubartelli A, Bonifaci N, Sitia R . 1995 Cancer Res. 55: 675–680

  • Ruppitsch W, Meißlitzer C, Hirsch-Kauffmann M, Schweiger M . 1998 FEBS Lett. 422: 99–102

  • Ruppitsch W, Meißlitzer C, Weirich-Schwaiger H, Klocker H, Scheidereit C, Schweiger M, Hirsch-Kauffmann M . 1997 Hum. Genet. 99: 710–719

  • Sambrook J, Fritsch FF, Maniatis T . 1989 Molecular Cloning: A laboratory manual Nolan, C. (ed) Cold Spring Harbor Laboratory Press, N.Y pp 712–715

  • Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K . 1994 Proc. Natl. Acad. Sci. USA 91: 1672–1676

  • Schindler D, Hoehn H . 1988 Am. J. Hum. Genet. 43: 429–435

  • Schreiber E, Matthias P, Müller MM, Schaffner W . 1989 Nucleic Acid Res. 15: 6419–

  • Sen CK, Packer L . 1996 FASEB J. 10: 709–720

  • Sittler A, Davys D, Weber C, Mandel JL . 1996 Human Mol. Genet. 1: 95–102

  • Wood JM, Schallreuter KU . 1991 Biochim. Biophys. Acta 1074: 378–385

Download references

Acknowledgements

We acknowledge with thanks Klaus Hennig for the overexpression and isolation of thioredoxin and Dr Rossi for raising antithioredoxin antibodies. We are very grateful to Prof Dr D Hirsch-Kauffmann Jokl, New York for editing suggestions. This work was possible through the generous support by grants from Thyssen-foundation (20002084).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manfred Schweiger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kontou, M., Adelfalk, C., Ramirez, M. et al. Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability. Oncogene 21, 2406–2412 (2002). https://doi.org/10.1038/sj.onc.1205299

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205299

Keywords

This article is cited by

Search

Quick links